Publications of U. Reichl

Ritter, J. B.; Genzel, Y.; Reichl, U.: Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in Culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)

Schulze-Horsel, J.; Bock, A.; Genzel, Y.; Reichl, U.: Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phase. GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)

Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.: Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)

Wolff, M. W.; Kalbfuss, B.; Opitz, L.; Zimmermann, A.; Lehmann, S.; Reichl, U.: Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)

Genzel, Y.; Schulze-Horsel, J.; Möhler, L.; Sidorenko, Y.; Reichl, U.: Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. 19th ESACT Meeting, Harrogate, UK (2005)

Heßeler, J.; Schmidt, J. K.; Reichl, U.; Flockerzi, D.: How to achieve coexistence in the chemostat: a combined mathematical and experimental approach. European Conference on Mathematical and Theoretical Biology (ECMTB), Dresden, Germany (2005)

Wolff, M.; Kalbfuss, B.; Morenweiser, R.; Zimmermann, A.; Reichl, U.: Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)

Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)

Genzel, Y.; König, S.; Reichl, U.: Amino acid analysis in mammalian cell culture based virus vaccine production processes. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)

Rapp, E.; Lubda, D.; Seidel-Morgenstern, A.; Reichl, U.; Tallarek, U.: Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass Spectromety. 37. Diskussionstagung der Deutschen Gesellschaft für Massenspektrometrie, Leipzig, Germany (2004)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M.; Baelkner, M.; Boehme, J.D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Piasecka, J.; Kupke, S. Y.; Reichl, U.: Genetically engineered influenza defective interfering particles with enhanced immune activation potential and antiviral efficacy in vitro. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 34^th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Kupke, S. Y.; Reichl, U.: The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 9^th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)

Dogra, T.; Pelz, L.; Rüdiger, D.; Hein, M. D.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y. et al.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Genetically engineered defective interfering particles for antiviral treatment and vaccination. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Jacobtorweihe, L.; Göbel, S.; Wolschek, M.; Altomonte, J.; Reichl, U.; Genzel, Y.: HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic Vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Jacobtorweihe, L.; Göbel, S.; Wolschek, M.; Altomonte, J.; Reichl, U.; Genzel, Y.: Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion Culture. Himmelfahrtstagung on Bioprocess Engineering 2024, Regensburg (Germany) (2024)

Jacobtorweihe, L.; Madeline, B.; Léon, A.; Genzel, Y.; Reichl, U.: Production of Oncolytic Newcastle Disease Virus in EB66 cells. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Küchler, J.; Opitz, P.; Jordan, I.; Genzel, Y.; Benndorf, D.; Reichl, U.: Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seed. 28th ESACT Meeting , Edingburgh (Scotland) (2024)